• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病及其他神经退行性运动障碍患者生命最后一年的医疗服务利用情况

Health Care Utilization in the Last Year of Life in Parkinson Disease and Other Neurodegenerative Movement Disorders.

作者信息

McKenzie Erica D, Bruno Veronica A, Fong Andrew, Cai Pin, Earp Madalene, Camicioli Richard M, de Kock Ingrid, Buttenschoen Daniela, Sinnarajah Aynharan, Miyasaki Janis

机构信息

Department of Clinical Neurosciences (EDM, VAB), Cumming School of Medicine, University of Calgary, AB, Canada; Data & Analytics (AF), Alberta Health Services, Calgary, Canada; Clinical Workforce Planning (PC, ME), Alberta Health Services, Calgary, Canada; Division of Neurology (RMC, JM), Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada; Department of Oncology (IK, DB), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada; and Department of Medicine (AS), School of Medicine, Queen's University, Kingston, Ontario Canada.

出版信息

Neurol Clin Pract. 2022 Dec;12(6):388-396. doi: 10.1212/CPJ.0000000000200092.

DOI:10.1212/CPJ.0000000000200092
PMID:36540145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9757116/
Abstract

BACKGROUND AND OBJECTIVES

Neurodegenerative movement disorders are rising in prevalence and are associated with high health care utilization. Generally, health care resources are disproportionately expended in the last year of life. Health care utilization by those with neurodegenerative movement disorders in the last year of life is not well-understood. The goal of this study was to assess the utilization of acute care in the last year of life among individuals with neurodegenerative movement disorders and determine whether outpatient neurology or palliative care affected acute care utilization and place of death.

METHODS

We conducted a retrospective cross-sectional study including health system administrative data in Alberta, Canada, from 2011 to 2017. Administrative data were used to determine place of death and quantify emergency department (ED) visits, hospitalizations, intensive care unit admissions, and outpatient generalist and specialist visits. Diagnoses were classified by 10th revision of the International Classification of Diseases codes. Stata 16v was used for statistical analyses.

RESULTS

Among 1439 individuals (60% male), Parkinson disease (n = 1226), progressive supranuclear palsy (n = 78), multiple system atrophy (n = 47), and Huntington disease (n = 58) were the most common diagnoses. The most frequent place of death was in hospital (45.9%), followed by long-term care (36.3%), home (7.9%), and residential hospice (4.0%). Most (64.2%) had >1 ED visit, and 14.4% had >3 emergency department visits. Fifty-five percent had >1 hospitalization, and 23.3% spent >30 days in hospital. Few (2.6%) were admitted to ICU. Only 37.2% and 8.8% accessed outpatient neurologist and specialist palliative care services, respectively. Multivariate logistic regression found the odds of dying at home was higher for those who received outpatient palliative consultation (OR, 2.49, 95% confidence interval [CI], 1.48-4.21, < 0.001) and were with a longer duration of home care support (OR, 1.0007, 95% CI, 1.0004-1.0009, < 0.001).

DISCUSSION

There are high rates of in-hospital death and acute care utilization in the year before death among those with neurodegenerative movement disorders. Most did not access specialist palliative or neurologic care in the last year of life. Outpatient palliative care and home care services were associated with increased odds of dying at home. Our results indicate the need for further research into the causes, costs, and potential modifiers to inform public health planning.

摘要

背景与目的

神经退行性运动障碍的患病率正在上升,且与高医疗保健利用率相关。一般来说,医疗保健资源在生命的最后一年中分配不均。神经退行性运动障碍患者在生命最后一年的医疗保健利用情况尚不清楚。本研究的目的是评估神经退行性运动障碍患者在生命最后一年的急性护理利用情况,并确定门诊神经科或姑息治疗是否会影响急性护理利用情况和死亡地点。

方法

我们进行了一项回顾性横断面研究,纳入了加拿大艾伯塔省2011年至2017年的卫生系统行政数据。行政数据用于确定死亡地点,并量化急诊就诊、住院、重症监护病房入院以及门诊全科医生和专科医生就诊情况。诊断依据国际疾病分类第10版代码进行分类。使用Stata 16v进行统计分析。

结果

在1439名个体(60%为男性)中,帕金森病(n = 1226)、进行性核上性麻痹(n = 78)、多系统萎缩(n = 47)和亨廷顿病(n = 58)是最常见的诊断。最常见的死亡地点是医院(45.9%),其次是长期护理机构(36.3%)、家中(7.9%)和住院临终关怀机构(4.0%)。大多数(64.2%)有超过1次急诊就诊,14.4%有超过3次急诊就诊。55%有超过1次住院,23.3%住院时间超过30天。很少有人(2.6%)入住重症监护病房。分别只有37.2%和8.8%的患者接受了门诊神经科医生和专科姑息治疗服务。多因素逻辑回归发现,接受门诊姑息治疗咨询的患者在家中死亡的几率更高(比值比[OR],2.49,95%置信区间[CI],1.48 - 4.21,P < 0.001),且接受家庭护理支持时间较长的患者在家中死亡的几率也更高(OR,1.0007,95% CI,1.0004 - 1.0009,P < 0.001)。

讨论

神经退行性运动障碍患者在死亡前一年的院内死亡率和急性护理利用率较高。大多数患者在生命的最后一年未接受专科姑息治疗或神经科护理。门诊姑息治疗和家庭护理服务与在家中死亡的几率增加相关。我们的结果表明需要进一步研究其原因、成本和潜在调节因素,以为公共卫生规划提供信息。

相似文献

1
Health Care Utilization in the Last Year of Life in Parkinson Disease and Other Neurodegenerative Movement Disorders.帕金森病及其他神经退行性运动障碍患者生命最后一年的医疗服务利用情况
Neurol Clin Pract. 2022 Dec;12(6):388-396. doi: 10.1212/CPJ.0000000000200092.
2
Impact of physician-based palliative care delivery models on health care utilization outcomes: A population-based retrospective cohort study.基于医生的姑息治疗提供模式对医疗保健利用结果的影响:一项基于人群的回顾性队列研究。
Palliat Med. 2021 Jun;35(6):1170-1180. doi: 10.1177/02692163211009440. Epub 2021 Apr 22.
3
Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study.姑息治疗与终末期非癌症成人医疗结局的关联:基于人群的匹配队列研究。
BMJ. 2020 Jul 6;370:m2257. doi: 10.1136/bmj.m2257.
4
Palliative home care and emergency department visits in the last 30 and 90 days of life: a retrospective cohort study of patients with cancer.生命最后30天和90天的姑息性家庭护理与急诊科就诊情况:一项针对癌症患者的回顾性队列研究
BMJ Support Palliat Care. 2024 Dec 19;14(e3):e2632-e2641. doi: 10.1136/bmjspcare-2021-002889.
5
Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.生命最后一年中呼吸系统疾病患者在医疗保健利用和死亡地点方面的城乡差异。
Rural Remote Health. 2010 Apr-Jun;10(2):1349. Epub 2010 Apr 30.
6
Children's Health Care Utilization and Cost in the Last Year of Life: A Cohort Comparison with and without Regional Specialist Pediatric Palliative Care.儿童在生命最后一年的医疗保健利用和费用:有和没有区域专科儿科姑息治疗的队列比较。
J Palliat Med. 2022 Jul;25(7):1031-1040. doi: 10.1089/jpm.2021.0175. Epub 2022 Jan 3.
7
Hospital-based acute care in the last 30 days of life among patients with chronic disease that received early, late or no specialist palliative care: a retrospective cohort study of eight chronic disease groups.在接受早期、晚期或无专科姑息治疗的慢性病患者生命最后 30 天的医院急性治疗:八个慢性病组的回顾性队列研究。
BMJ Open. 2021 Mar 24;11(3):e044196. doi: 10.1136/bmjopen-2020-044196.
8
Acute hospital-based services used by adults during the last year of life in New South Wales, Australia: a population-based retrospective cohort study.澳大利亚新南威尔士州成年人生命最后一年所使用的急性医院服务:一项基于人群的回顾性队列研究。
BMC Health Serv Res. 2015 Dec 4;15:537. doi: 10.1186/s12913-015-1202-8.
9
The Impact of Community-Based Palliative Care on Utilization and Cost of Acute Care Hospital Services in the Last Year of Life.社区姑息治疗对生命最后一年急性护理医院服务利用情况及成本的影响。
J Palliat Med. 2017 Jul;20(7):736-744. doi: 10.1089/jpm.2016.0417. Epub 2017 Feb 16.
10
Trends in site of death and health care utilization at the end of life: a population-based cohort study.临终时死亡地点及医疗保健利用的趋势:一项基于人群的队列研究。
CMAJ Open. 2019 Apr 26;7(2):E306-E315. doi: 10.9778/cmajo.20180097. Print 2019 Apr-Jun.

引用本文的文献

1
Neuropalliative Care in the Emergency Department: Three Roles, One Goal.急诊科的神经姑息治疗:三个角色,一个目标。
Neurocrit Care. 2025 Sep 4. doi: 10.1007/s12028-025-02361-7.
2
Palliative care pathways in Amyotrophic Lateral Sclerosis (ALS): a sequence analysis of health claims data.肌萎缩侧索硬化症(ALS)的姑息治疗路径:健康索赔数据的序列分析
BMC Palliat Care. 2025 Jul 14;24(1):200. doi: 10.1186/s12904-025-01843-x.
3
MeDeMSA care study protocol: developing personalized best medical care with integrated mobile palliative and telemedicine support for individuals with multiple system atrophy.多系统萎缩患者的移动医疗与远程医疗支持个性化最佳医疗护理研究方案:开发个性化最佳医疗护理
J Neural Transm (Vienna). 2025 May 24. doi: 10.1007/s00702-025-02933-z.
4
Health care utilization at the end of life in Parkinson's disease: a population-based register study.帕金森病患者生命终末期的医疗保健利用情况:一项基于人群的登记研究。
BMC Palliat Care. 2024 Oct 29;23(1):251. doi: 10.1186/s12904-024-01581-6.
5
End-of-Life Healthcare Utilization in Lewy Body Dementia.路易体痴呆的终末医疗保健利用。
J Alzheimers Dis. 2024;101(1):133-145. doi: 10.3233/JAD-240194.
6
Unique characteristics of end-of-life hospitalizations in Parkinson disease.帕金森病临终住院的独特特征。
Front Aging Neurosci. 2023 Oct 12;15:1254969. doi: 10.3389/fnagi.2023.1254969. eCollection 2023.
7
Neurologists and Palliative Care: Are We Doing Enough?神经科医生与姑息治疗:我们做得够吗?
Neurol Clin Pract. 2022 Dec;12(6):386-387. doi: 10.1212/CPJ.0000000000200114.

本文引用的文献

1
Hospital-based acute care in the last 30 days of life among patients with chronic disease that received early, late or no specialist palliative care: a retrospective cohort study of eight chronic disease groups.在接受早期、晚期或无专科姑息治疗的慢性病患者生命最后 30 天的医院急性治疗:八个慢性病组的回顾性队列研究。
BMJ Open. 2021 Mar 24;11(3):e044196. doi: 10.1136/bmjopen-2020-044196.
2
Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.比较综合门诊姑息治疗与标准治疗对帕金森病及相关疾病患者的效果:一项随机临床试验。
JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992.
3
Implications of Palliative Care Consultation Timing among a Cohort of Hospice Decedents.姑息治疗咨询时机对一组 Hospice 逝者的影响。
J Palliat Med. 2019 Sep;22(9):1129-1132. doi: 10.1089/jpm.2018.0514. Epub 2019 Mar 13.
4
Defining Palliative Care Needs in Parkinson's Disease.确定帕金森病的姑息治疗需求
Mov Disord Clin Pract. 2018 Nov 16;6(2):125-131. doi: 10.1002/mdc3.12702. eCollection 2019 Feb.
5
The Role of Palliative Care in Chronic Progressive Neurological Diseases-A Survey Amongst Neurologists in the Netherlands.姑息治疗在慢性进行性神经系统疾病中的作用——荷兰神经科医生的一项调查
Front Neurol. 2019 Jan 14;9:1157. doi: 10.3389/fneur.2018.01157. eCollection 2018.
6
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
7
Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson's Disease Patients.德国晚期帕金森病患者队列中的生活质量受损及姑息治疗需求
Front Neurol. 2018 Mar 6;9:120. doi: 10.3389/fneur.2018.00120. eCollection 2018.
8
Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.7 个发达国家癌症死亡患者的死亡地点、医疗保健利用情况和医院支出比较。
JAMA. 2016 Jan 19;315(3):272-83. doi: 10.1001/jama.2015.18603.
9
Neurologist ambulatory care, health care utilization, and costs in a large commercial dataset.大型商业数据集中的神经科门诊护理、医疗保健利用情况及成本
Neurology. 2016 Jan 26;86(4):367-74. doi: 10.1212/WNL.0000000000002276. Epub 2015 Dec 23.
10
Nursing home and end-of-life care in Parkinson disease.帕金森病的养老院及临终关怀
Neurology. 2015 Aug 4;85(5):413-9. doi: 10.1212/WNL.0000000000001715. Epub 2015 Jul 2.